Effect of Chronic Aspirin Therapy on Angiographic Thrombotic Burden in Patients Admitted for a First ST-Elevation Myocardial Infarction

American Journal of Cardiology

Volumn 105, Issue 5, 2010, Pages 587-591

  Niccoli, Giampaolo ^a   Spaziani, Cristina ^a   Marino, Marcello ^a   Pontecorvo, Maria Luisa ^a   Cosentino, Nicola ^a   Bacà, Marco ^a   Porto, Italo ^a   Leone, Antonio Maria ^a   Crea, Filippo ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY STENT; DISEASE SEVERITY; FEMALE; HEART INFARCTION; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; ST SEGMENT ELEVATION; THROMBUS;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ASPIRIN; COHORT STUDIES; CORONARY ANGIOGRAPHY; CORONARY THROMBOSIS; DRUG ADMINISTRATION SCHEDULE; FEMALE; FIBRINOLYTIC AGENTS; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 76849100748     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.10.040     Document Type: Article

References (30)

1. Van der Werf F., Bax J., Betriu A., Blomstrom-Lundqvist C., Crea F., Falk V., Filippatos G., Fox K., Huber K., Kastrati A., Rosengren A., Steg P.G., Tubaro M., Verheugt F., Weidinger F., Weis M., ESC Committee for Practice Guidelines (CPG), Vahanian A., Camm J., De Caterina R., Dean V., Dickstein K., Filippatos G., Funck-Brentano C., Hellemans I., Kristensen S.D., McGregor K., Sechtem U., Silber S., Tendera M., Widimsky P., Zamorano J.L., Silber S., Aguirre F.V., Al-Attar N., Alegria E., Andreotti F., Benzer W., Breithardt O., Danchin N., Di Mario C., Dudek D., Gulba D., Halvorsen S., Kaufmann P., Kornowski R., Lip G.Y., and Rutten F. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation. Eur Heart J 29 (2008) 2909-2945
2. Vlaar P.J., Svilaas T., van der Hors I.C., Diercks G.F., Fokkema M.L., de Smet B.J., van den Heuvel A.F., Anthonio R.L., Jessurun G.A., Tan E.S., Suurmeijer A.J., and Zijlstra F. Cardiac death and reinfarction after 1 year in the Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS): a 1-year follow-up study. Lancet 371 (2008) 1915-1920
3. Burzotta F., Trani C., Romagnoli E., Mazzari M.A., Rebuzzi A.G., De Vita M., Garramone B., Giannico F., Niccoli G., Biondi-Zoccai G.G., Schiavoni G., Mongiardo R., and Crea F. Manual thrombus-aspiration improves myocardial reperfusion: the randomized evaluation of the effect of mechanical reduction of distal embolization by thrombus-aspiration in primary and rescue angioplasty (REMEDIA) trial. J Am Coll Cardiol 46 (2005) 371-376
4. Pollack Jr. C. Pharmacological and mechanical revascularization strategies in STEMI: integration of two approaches. J Invasive Cardiol 20 (2008) 231-238
5. Thiele H., Schindler K., Friedenberger J., Eitel I., Fürnau G., Grebe E., Erbs S., Linke A., Möbius-Winkler S., Kivelitz D., and Schuler G. Intracoronary compared with intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: the randomized Leipzig immediate percutaneous coronary intervention abciximab IV versus IC in ST-elevation myocardial infarction trial. Circulation 118 (2008) 49-57
6. Garcia-Dorado D., Theroux P., Tornos P., Sambola A., Oliveras J., Santos M., and Soler Soler J. Previous aspirin use may attenuate the severity of the manifestation of acute ischemic syndromes. Circulation 92 (1995) 1743-1748
7. Kennon S., Barakat K., Suliman A., MacCallum P.K., Ranjadayalan K., Wilkinson P., and Timmis A.D. Influence of previous aspirin treatment and smoking on the electrocardiographic manifestations of injury in acute myocardial infarction. Heart 84 (2000) 41-45
8. Abdelnoor M., and Landmark K. Infarct size is reduced and the frequency of non-Q-wave myocardial infarctions is increased in patients using aspirin at the onset of symptoms. Cardiology 91 (1999) 119-126
9. Rentrop K.P., Cohen M., Blanke H., and Phillips R.A. Changes in collateral channel filling immediately after controlled coronary artery occlusion b an angioplasty balloon in human subjects. J Am Coll Cardiol 5 (1985) 587-592
10. Roberts W.L., Sedrick R., Moulton L., Spencer A., and Rifai N. Evaluation of four automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Clin Chem 46 (2000) 461-468
11. Gibson C.M., de Lemos J.A., Murphy S.A., Marble S.J., McCabe C.H., Cannon C.P., Antman E.M., Braunwald E., and TIMI Study Group. Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudy. Circulation 103 (2001) 2550-2554
12. Miranda-Guardiola F., Rossi A., Serra A., Garcia B., Rumoroso J.R., Iñiguez A., Vaquerizo B., Triano J.L., Sierra G., Bruguera J., and Spanish AMIcath Registry. Angiographic quantification of thrombus in ST-elevation acute myocardial infarction presenting with an occluded infarct-related artery and its relationship with results of percutaneous intervention. J Interv Cardiol 22 (2009) 207-215
13. Patrono C., and Rocca B. Aspirin: promise and resistance in the new millennium. Arterioscler Thromb Vasc Biol 28 (2008) s25-s32
14. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 2 (1988) 349-360
15. Fitzgerald D.J., Catella F., Roy L., and FitzGerald G.A. Marked platelet activation in vivo after intravenous streptokinase in patients with acute myocardial infarction. Circulation 77 (1988) 142-150
16. Freimark D., Matetzky S., Leor J., Boyko V., Barbash I.M., Behar S., and Hod H. Timing of aspirin administration as a determinant of survival of patients with acute myocardial infarction treated with thrombolysis. Am J Cardiol 89 (2002) 381-385
17. Patrono C., Garcia Rodriguez L.A., Landolfi R., and Baigent C. Low-dose aspirin for the prevention of atherothrombosis. N Engl J Med 353 (2005) 2373-2383
18. Sanmuganathan P.S., Ghahramani P., Jackson P.R., Wallis E.J., and Ramsay L.E. Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomized trials. Heart 85 (2001) 265-271
19. Tefone A., Cerbone A.M., and Di Minno G. The use of antithrombotic drugs in older people. Minerva Med 93 (2002) 13-26
20. Weber A.A., Liesener S., Hohlfeld T., and Schror K. 40 mg of aspirin are not sufficient to inhibit platelet function under conditions of limited compliance. Thromb Res 97 (2000) 365-367
21. Bhatt D.L., Fox K.A., Hacke W., Berger P.B., Black H.R., Boden W.E., Cacoub P., Cohen E.A., Creager M.A., Easton J.D., Flather M.D., Haffner S.M., Hamm C.W., Hankey G.J., Johnston S.C., Mak K.H., Mas J.L., Montalescot G., Pearson T.A., Steg P.G., Steinhubl S.R., Weber M.A., Brennan D.M., Fabry-Ribaudo L., Booth J., Topol E.J., and CHARISMA Investigators. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 354 (2006) 1706-1017
22. Gibson M., Barron H.V., Cannon C.P., Murphy S.A., and Braunwald E. Association between white blood cell count, epicardial blood flow, myocardial perfusion, and clinical outcomes in the setting of acute myocardial infarction: a Thrombolysis In Myocardial Infarction 10 substudy. Circulation 102 (2000) 2329-2334
23. Sanchis J., Bodí V., Núñez J., Bertomeu V., Consuegra L., Bosch M.J., Gómez C., Bosch X., Chorro F.J., and Llácer A. Prognostic usefulness of white blood cell count on admission and one-year outcome in patients with non-ST-segment elevation acute chest pain. Am J Cardiol 98 (2006) 885-889
24. Barron H.V., Harr S.D., Radford M.J., Wang Y., and Krumholz H.M. The association between white blood cell count and acute myocardial infarction mortality in patients > or = 65 years of age: findings from the Global Registry of Acute Coronary Events (GRACE). J Am Coll Cardiol 38 (2001) 1654-1661
25. Ma X.L., Tsao P.S., and Lefer A.M. Antibody to CD-18 exerts endothelial and cardiac protective effects in myocardial ischemia and reperfusion. J Clin Invest 88 (1991) 1237-1243
26. Marx N., Neumann F.J., Ott I., Gawaz M., Koch W., Pinkau T., and Schömig A. Induction of cytokine expression in leukocytes in acute myocardial infarction. J Am Coll Cardiol 30 (1997) 165-170
27. Kloner R.A., Ganote C.E., and Jennings R.B. The "no-reflow" phenomenon after temporary coronary occlusion in the dog. J Clin Invest 54 (1974) 1496-1508
28. Pinto D.S., Kirtane A.J., Pride Y.B., Murphy S.A., Sabatine M.S., Cannon C.P., Gibson C.M., and CLARITY-TIMI-28 investigators. Association of blood glucose with angiographic and clinical outcomes among patients with ST-segment elevation myocardial infarction (from the CLARITY-TIMI-28 study). Am J Cardiol 101 (2008) 303-307
29. Gasior M., Pres D., Stasik-Pres G., Lech P., Gierlotka M., Hawranek M., Wilczek K., Szyguła-Jurkiewicz B., Lekston A., Kalarus Z., Strojek K., and Gumprecht J.P.L. Effect of blood glucose levels on prognosis in acute myocardial infarction in patients with and without diabetes, undergoing percutaneous coronary intervention. Cardiol J 15 (2008) 422-430
30. Vaidyula V.R., Boden G., and Rao A.K. Platelet and monocytes activation by hyperglycemia and hyperinsulinemia in healthy subjects. Platelets 17 (2006) 577-585